GI-181771X is a novel, potent and orally bioavailable CCK-1 (cholecystokinin 1) agonist with the potential for the treatment of obesity. GI-181771X effects satiation and gastric and gallbladder emptying.

纯度：≥98%

CAS：305366-98-7